Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 210

1.

Towards the Limits of Existence of Nuclear Structure: Observation and First Spectroscopy of the Isotope ^{31}K by Measuring Its Three-Proton Decay.

Kostyleva D, Mukha I, Acosta L, Casarejos E, Chudoba V, Ciemny AA, Dominik W, Dueñas JA, Dunin V, Espino JM, Estradé A, Farinon F, Fomichev A, Geissel H, Gorshkov A, Grigorenko LV, Janas Z, Kamiński G, Kiselev O, Knöbel R, Krupko S, Kuich M, Litvinov YA, Marquinez-Durán G, Martel I, Mazzocchi C, Nociforo C, Ordúz AK, Pfützner M, Pietri S, Pomorski M, Prochazka A, Rymzhanova S, Sánchez-Benítez AM, Scheidenberger C, Simon H, Sitar B, Slepnev R, Stanoiu M, Strmen P, Szarka I, Takechi M, Tanaka YK, Weick H, Winkler M, Winfield JS, Xu X, Zhukov MV.

Phys Rev Lett. 2019 Aug 30;123(9):092502. doi: 10.1103/PhysRevLett.123.092502.

PMID:
31524489
2.

Safety and immunogenicity of a replication-deficient H5N1 influenza virus vaccine lacking NS1.

Nicolodi C, Groiss F, Kiselev O, Wolschek M, Seipelt J, Muster T.

Vaccine. 2019 Jun 19;37(28):3722-3729. doi: 10.1016/j.vaccine.2019.05.013. Epub 2019 May 30.

PMID:
31155415
3.

Safety and efficacy of p62 DNA vaccine ELENAGEN in a first-in-human trial in patients with advanced solid tumors.

Ponomarenko DM, Klimova ID, Chapygina YA, Dvornichenko VV, Zhukova NV, Orlova RV, Manikhas GM, Zyryanov AV, Burkhanova LA, Badrtdinova II, Oshchepkov BN, Filippova EV, Orlov SV, Kolesnikov SI, Sufianov AA, Baum SR, Zaitzeva OY, Komissarov AB, Grudinin MP, Kiselev OI, Tsyb AF, Venanzi F, Shcherbinina V, Chursov A, Gabai VL, Shneider AM.

Oncotarget. 2017 Mar 25;8(32):53730-53739. doi: 10.18632/oncotarget.16574. eCollection 2017 Aug 8.

4.

[Adenosine A2A receptor as a drug target for treatment of sepsis].

Sivak KV, Vasin AV, Egorov VV, Tsevtkov VB, Kuzmich NN, Savina VA, Kiselev OI.

Mol Biol (Mosk). 2016 Mar-Apr;50(2):231-45. doi: 10.7868/S0026898416020233. Review. Russian.

5.

The influenza A virus NS genome segment displays lineage-specific patterns in predicted RNA secondary structure.

Vasin AV, Petrova AV, Egorov VV, Plotnikova MA, Klotchenko SA, Karpenko MN, Kiselev OI.

BMC Res Notes. 2016 May 20;9:279. doi: 10.1186/s13104-016-2083-6.

6.

[ANTIVIRAL ACTIVITY OF THE DIHYDROQUERCETIN DURING THE COXSACKIEVIRUS B4 REPLICATION IN VITRO].

Galochkina AV, Zarubaev VV, Kiselev OI, Babkin VA, Ostroukhova LA.

Vopr Virusol. 2016;61(1):27-31. Russian.

PMID:
27145597
7.

[Oncolytic potential of recombinant influenza A virus vectors on a model of malignant glioma in vivo].

Shurygina APS, Kartashev AV, Kovanko EG, Kiseleva LN, Pustovalov YI, Slita AK, Zarubaev VV, Belyaevskaya SV, Sirotkin AK, Kiselev OI, Egorov AY.

Vopr Onkol. 2016;62(1):138-45. Russian.

PMID:
30444592
8.

CHRONIC HEPATITIS WITH DOUBLE B/C INFECTION: VIROLOGICAL, CLINICAL, MORPHOLOGICAL CHARACTERISTICS.

Dudanova OP, Shubina ME, Belavina IA, Elpaeva EA, Pisareva MM, Grudinin MP, Kiselev OI.

Klin Med (Mosk). 2016;94(4):289-294.

PMID:
28957609
9.

Observation and Spectroscopy of New Proton-Unbound Isotopes ³⁰Ar and ²⁹Cl: An Interplay of Prompt Two-Proton and Sequential Decay.

Mukha I, Grigorenko LV, Xu X, Acosta L, Casarejos E, Ciemny AA, Dominik W, Duénas-Díaz J, Dunin V, Espino JM, Estradé A, Farinon F, Fomichev A, Geissel H, Golubkova TA, Gorshkov A, Janas Z, Kamiński G, Kiselev O, Knöbel R, Krupko S, Kuich M, Litvinov YA, Marquinez-Durán G, Martel I, Mazzocchi C, Nociforo C, Ordúz AK, Pfützner M, Pietri S, Pomorski M, Prochazka A, Rymzhanova S, Sánchez-Benítez AM, Scheidenberger C, Sharov P, Simon H, Sitar B, Slepnev R, Stanoiu M, Strmen P, Szarka I, Takechi M, Tanaka YK, Weick H, Winkler M, Winfield JS, Zhukov MV.

Phys Rev Lett. 2015 Nov 13;115(20):202501. doi: 10.1103/PhysRevLett.115.202501. Epub 2015 Nov 9.

PMID:
26613434
10.

Discovery of a new class of antiviral compounds: camphor imine derivatives.

Sokolova AS, Yarovaya OI, Shernyukov AV, Gatilov YV, Razumova YV, Zarubaev VV, Tretiak TS, Pokrovsky AG, Kiselev OI, Salakhutdinov NF.

Eur J Med Chem. 2015 Nov 13;105:263-73. doi: 10.1016/j.ejmech.2015.10.010. Epub 2015 Oct 22.

PMID:
26498572
11.

Interleukin-24 inhibits influenza A virus replication in vitro through induction of toll-like receptor 3 dependent apoptosis.

Weiss R, Laengle J, Sachet M, Shurygina AP, Kiselev O, Egorov A, Bergmann M.

Antiviral Res. 2015 Nov;123:93-104. doi: 10.1016/j.antiviral.2015.09.005. Epub 2015 Sep 11.

PMID:
26367324
12.

[Ebola hemorrhagic fever: Properties of the pathogen and development of vaccines and chemotherapeutic agents].

Kiselev OI, Vasin AV, Shevyryova MP, Deeva EG, Sivak KV, Egorov VV, Tsvetkov VB, Egorov AY, Romanovskaya-Romanko EA, Stepanova LA, Komissarov AB, Tsybalova LM, Ignatjev GM.

Mol Biol (Mosk). 2015 Jul-Aug;49(4):541-54. doi: 10.7868/S0026898415040072. Russian.

13.

[Comparison of the influenza epidemics in Russia caused by the pandemic virus A(H1N1)pdm09 within the period from 2009 to 2013].

Karpova LS, Sominina AA, Burtseva EI, Pelikh MY, Feodoritova EL, Popovtseva NM, Stolyarov TP, Kiselev OI.

Vopr Virusol. 2015;60(3):19-24. Russian.

PMID:
26281302
14.

A genetically adjuvanted influenza B virus vector increases immunogenicity and protective efficacy in mice.

Kittel C, Wressnigg N, Shurygina AP, Wolschek M, Stukova M, Romanovskaya-Romanko E, Romanova J, Kiselev O, Muster T, Egorov A.

Arch Virol. 2015 Oct;160(10):2525-34. doi: 10.1007/s00705-015-2525-9. Epub 2015 Jul 28.

PMID:
26215439
15.

Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant region of hepatitis B core antigen: Broad protective efficacy of particles carrying four copies of M2e.

Tsybalova LM, Stepanova LA, Kuprianov VV, Blokhina EA, Potapchuk MV, Korotkov AV, Gorshkov AN, Kasyanenko MA, Ravin NV, Kiselev OI.

Vaccine. 2015 Jun 26;33(29):3398-406. doi: 10.1016/j.vaccine.2015.04.073. Epub 2015 May 11.

PMID:
25976545
16.

[Clinical efficacy of arbidol (umifenovir) in the therapy of influenza in adults: preliminary results of the multicenter double-blind randomized placebo-controlled study ARBITR].

Kiselev OI, Maleev VV, Deeva EG, Leneva IA, Selkova EP, Osipova EA, Obukhov AA, Nadorov SA, Kulikova EV.

Ter Arkh. 2015;87(1):88-96. doi: 10.17116/terarkh201587188-96. Russian.

PMID:
25823275
17.

Glycyrrhizic acid derivatives as influenza A/H1N1 virus inhibitors.

Baltina LA, Zarubaev VV, Baltina LA, Orshanskaya IA, Fairushina AI, Kiselev OI, Yunusov MS.

Bioorg Med Chem Lett. 2015 Apr 15;25(8):1742-1746. doi: 10.1016/j.bmcl.2015.02.074. Epub 2015 Mar 7.

PMID:
25801933
18.

Protection against multiple influenza A virus strains induced by candidate recombinant vaccine based on heterologous M2e peptides linked to flagellin.

Stepanova LA, Kotlyarov RY, Kovaleva AA, Potapchuk MV, Korotkov AV, Sergeeva MV, Kasianenko MA, Kuprianov VV, Ravin NV, Tsybalova LM, Skryabin KG, Kiselev OI.

PLoS One. 2015 Mar 23;10(3):e0119520. doi: 10.1371/journal.pone.0119520. eCollection 2015.

19.

Identification of genetic determinants of influenza A virus resistance to adamantanes and neuraminidase inhibitors using biological microarray.

Heydarov RN, Fesenko EE, Shaskolskiy BL, Klotchenko SA, Vasin AV, Titov SV, Dementieva EI, Zasedatelev AS, Mikhailovich VM, Kiselev OI.

Dokl Biochem Biophys. 2015;460:4-8. doi: 10.1134/S1607672915010032. Epub 2015 Mar 13. No abstract available.

PMID:
25772979
20.

[The use of apoptosis inducers in the therapy of experimental influenza infection and preventing of chronic post-influenza lung damage].

Zarubaev VV, Tribulovich VG, Beliavskaia SV, Barlev NA, Kiselev OI.

Tsitologiia. 2014;56(3):241-7. Russian.

PMID:
25509421
21.

Novel derivatives of usnic acid effectively inhibiting reproduction of influenza A virus.

Shtro AA, Zarubaev VV, Luzina OA, Sokolov DN, Kiselev OI, Salakhutdinov NF.

Bioorg Med Chem. 2014 Dec 15;22(24):6826-36. doi: 10.1016/j.bmc.2014.10.033. Epub 2014 Oct 31.

PMID:
25464881
22.

Synthesis and antiviral activity of PB1 component of the influenza A RNA polymerase peptide fragments.

Matusevich OV, Egorov VV, Gluzdikov IA, Titov MI, Zarubaev VV, Shtro AA, Slita AV, Dukov MI, Shurygina AP, Smirnova TD, Kudryavtsev IV, Vasin AV, Kiselev OI.

Antiviral Res. 2015 Jan;113:4-10. doi: 10.1016/j.antiviral.2014.10.015. Epub 2014 Nov 12.

PMID:
25446335
23.

First observation of the unbound nucleus 15Ne.

Wamers F, Marganiec J, Aksouh F, Aksyutina Y, Álvarez-Pol H, Aumann T, Beceiro-Novo S, Boretzky K, Borge MJ, Chartier M, Chatillon A, Chulkov LV, Cortina-Gil D, Emling H, Ershova O, Fraile LM, Fynbo HO, Galaviz D, Geissel H, Heil M, Hoffmann DH, Johansson HT, Jonson B, Karagiannis C, Kiselev OA, Kratz JV, Kulessa R, Kurz N, Langer C, Lantz M, Le Bleis T, Lemmon R, Litvinov YA, Mahata K, Müntz C, Nilsson T, Nociforo C, Nyman G, Ott W, Panin V, Paschalis S, Perea A, Plag R, Reifarth R, Richter A, Rodriguez-Tajes C, Rossi D, Riisager K, Savran D, Schrieder G, Simon H, Stroth J, Sümmerer K, Tengblad O, Weick H, Wimmer C, Zhukov MV.

Phys Rev Lett. 2014 Apr 4;112(13):132502. Epub 2014 Apr 4.

PMID:
24745409
24.

Molecular mechanisms enhancing the proteome of influenza A viruses: an overview of recently discovered proteins.

Vasin AV, Temkina OA, Egorov VV, Klotchenko SA, Plotnikova MA, Kiselev OI.

Virus Res. 2014 Jun 24;185:53-63. doi: 10.1016/j.virusres.2014.03.015. Epub 2014 Mar 24. Review.

PMID:
24675275
25.

[Universal diagnostic oligonucleotide microarray for subtyping of human and animal influenza A viruses].

Vasin AV, Sandybaev NT, Plotnikova MA, Klotchenko SA, Cherviakova OV, Strochkov VM, Taĭlakova ÉT, Temkina OA, Brodskaia AV, Zabrodskaia IaA, Nikulenkov KP, Egorov VV, Koshemetov ZhK, Sancyzbaĭ AR, Kiselev OI.

Vopr Virusol. 2013 Sep-Oct;58(5):32-7. Russian.

PMID:
24640169
26.

Camphor-based symmetric diimines as inhibitors of influenza virus reproduction.

Sokolova AS, Yarovaya OC, Korchagina DV, Zarubaev VV, Tretiak TS, Anfimov PM, Kiselev OI, Salakhutdinov NF.

Bioorg Med Chem. 2014 Apr 1;22(7):2141-8. doi: 10.1016/j.bmc.2014.02.038. Epub 2014 Mar 1.

PMID:
24631360
27.

Assessment of human immune responses to H7 avian influenza virus of pandemic potential: results from a placebo-controlled, randomized double-blind phase I study of live attenuated H7N3 influenza vaccine.

Rudenko L, Kiseleva I, Naykhin AN, Erofeeva M, Stukova M, Donina S, Petukhova G, Pisareva M, Krivitskaya V, Grudinin M, Buzitskaya Z, Isakova-Sivak I, Kuznetsova S, Larionova N, Desheva J, Dubrovina I, Nikiforova A, Victor JC, Neuzil K, Flores J, Tsvetnitsky V, Kiselev O.

PLoS One. 2014 Feb 12;9(2):e87962. doi: 10.1371/journal.pone.0087962. eCollection 2014.

28.

Measurement of the dipole polarizability of the unstable neutron-rich nucleus 68Ni.

Rossi DM, Adrich P, Aksouh F, Alvarez-Pol H, Aumann T, Benlliure J, Böhmer M, Boretzky K, Casarejos E, Chartier M, Chatillon A, Cortina-Gil D, Datta Pramanik U, Emling H, Ershova O, Fernandez-Dominguez B, Geissel H, Gorska M, Heil M, Johansson HT, Junghans A, Kelic-Heil A, Kiselev O, Klimkiewicz A, Kratz JV, Krücken R, Kurz N, Labiche M, Le Bleis T, Lemmon R, Litvinov YA, Mahata K, Maierbeck P, Movsesyan A, Nilsson T, Nociforo C, Palit R, Paschalis S, Plag R, Reifarth R, Savran D, Scheit H, Simon H, Sümmerer K, Wagner A, Waluś W, Weick H, Winkler M.

Phys Rev Lett. 2013 Dec 13;111(24):242503. Epub 2013 Dec 10.

PMID:
24483648
29.

Structural Features of the Peptide Homologous to 6-25 Fragment of Influenza A PB1 Protein.

Egorov VV, Matusevich OV, Shaldzhyan AA, Skvortsov AN, Zabrodskaya YA, Garmay YP, Landa SB, Lebedev DV, Zarubayev VV, Sirotkin AK, Vasin AV, Kiselev OI.

Int J Pept. 2013;2013:370832. doi: 10.1155/2013/370832. Epub 2013 Dec 24.

30.

Adaptive mutation in nuclear export protein allows stable transgene expression in a chimaeric influenza A virus vector.

Kuznetsova I, Shurygina AP, Wolf B, Wolschek M, Enzmann F, Sansyzbay A, Khairullin B, Sandybayev N, Stukova M, Kiselev O, Egorov A, Bergmann M.

J Gen Virol. 2014 Feb;95(Pt 2):337-49. doi: 10.1099/vir.0.056036-0. Epub 2013 Nov 12.

PMID:
24222196
31.

Broad-spectrum anti-tumor and anti-metastatic DNA vaccine based on p62-encoding vector.

Venanzi F, Shifrin V, Sherman M, Gabai V, Kiselev O, Komissarov A, Grudinin M, Shartukova M, Romanovskaya-Romanko EA, Kudryavets Y, Bezdenezhnykh N, Lykhova O, Semesyuk N, Concetti A, Tsyb A, Filimonova M, Makarchuk V, Yakubovsky R, Chursov A, Shcherbinina V, Shneider A.

Oncotarget. 2013 Oct;4(10):1829-35.

32.

[Intranasal co-administration of recombinant streptococcus group B polypeptides and influenza deltaNS1 vaccine].

Shurygina AP, Leont'eva GF, Grabovskaia KB, Gupalova TV, Koroleva IV, Kramskaia TA, Kiselev OI, Egorov AIu, Suvorov AN.

Vopr Virusol. 2013 May-Jun;58(3):28-31. Russian.

PMID:
24006630
33.

New quaternary ammonium camphor derivatives and their antiviral activity, genotoxic effects and cytotoxicity.

Sokolova AS, Yarovaya CO, Shernyukov CA, Pokrovsky CE, Pokrovsky CA, Lavrinenko VA, Zarubaev VV, Tretiak TS, Anfimov PM, Kiselev OI, Beklemishev AB, Salakhutdinov NF.

Bioorg Med Chem. 2013 Nov 1;21(21):6690-8. doi: 10.1016/j.bmc.2013.08.014. Epub 2013 Aug 12.

PMID:
23993669
34.

Study of immunogenicity of recombinant proteins based on hemagglutinin and neuraminidase conservative epitopes of influenza A virus.

Dukhovlinov I, Al-Shekhadat R, Fedorova E, Stepanova L, Potapchuk M, Repko I, Rusova O, Orlov A, Tsybalova L, Kiselev O.

Med Sci Monit Basic Res. 2013 Aug 23;19:221-7. doi: 10.12659/MSMBR.884002.

35.

An inactivated, adjuvanted whole virion clade 2.2 H5N1 (A/Chicken/Astana/6/05) influenza vaccine is safe and immunogenic in a single dose in humans.

Sansyzbay AR, Erofeeva MK, Khairullin BM, Sandybayev NT, Kydyrbayev ZK, Mamadaliyev SM, Kassenov MM, Sergeeva MV, Romanova JR, Krivitskaya VZ, Kiselev OI, Stukova MA.

Clin Vaccine Immunol. 2013 Aug;20(8):1314-9. doi: 10.1128/CVI.00096-13. Epub 2013 Jun 26.

36.

New constraint on the existence of the μ+ → e+ γ decay.

Adam J, Bai X, Baldini AM, Baracchini E, Bemporad C, Boca G, Cattaneo PW, Cavoto G, Cei F, Cerri C, de Bari A, De Gerone M, Doke T, Dussoni S, Egger J, Fujii Y, Galli L, Gatti F, Golden B, Grassi M, Graziosi A, Grigoriev DN, Haruyama T, Hildebrandt M, Hisamatsu Y, Ignatov F, Iwamoto T, Kaneko D, Kettle PR, Khazin BI, Khomotov N, Kiselev O, Korenchenko A, Kravchuk N, Lim G, Maki A, Mihara S, Molzon W, Mori T, Mzavia D, Nardò R, Natori H, Nicolò D, Nishiguchi H, Nishimura Y, Ootani W, Panareo M, Papa A, Piredda G, Popov A, Renga F, Ripiccini E, Ritt S, Rossella M, Sawada R, Sergiampietri F, Signorelli G, Suzuki S, Tenchini F, Topchyan C, Uchiyama Y, Voena C, Xiao F, Yamada S, Yamamoto A, Yamashita S, You Z, Yudin YV, Zanello D; MEG Collaboration.

Phys Rev Lett. 2013 May 17;110(20):201801. Epub 2013 May 13.

PMID:
25167396
37.

[Genetic diversity and molecular evolution of the influenza A viruses in Russia during 2006-2012].

Grudinin MP, Komissarov AB, Pisareva MM, Stukova MA, Buzitskaia ZhV, Paiankova AA, Elpaeva EA, Zadonskaia AV, Ivanov IuV, Kiselev OI.

Vopr Virusol. 2012 Nov-Dec;57(6):37-42. Russian.

PMID:
23477253
38.

[Development of novel drugs against influenza virus based on synthetic and natural compounds].

Zarubaev VV, Anfimov PM, Shtro AA, Garshinina AV, Meleshkina IA, Karpinskaia LA, Kozeletskaia KN, Kiselev OI.

Vopr Virusol. 2012 Nov-Dec;57(6):30-6. Russian.

PMID:
23477252
39.

[Characterization of cold-adapted influenza strain A/HongKong/1/68/162/35 as a potential donor of attenuation and high reproduction].

Tsybalova LM, Gorev NE, Potapchuk MV, Repko IA, Korotkov AV, Sergeeva MV, Komissarov AB, Pisareva MM, Kuznetsov VV, Grudinin MP, Kiselev OI.

Vopr Virusol. 2012 Nov-Dec;57(6):13-7. Russian.

PMID:
23477248
40.

[A new antiviral drug Triazavirin: results of phase II clinical trial].

Kiselev OI, Deeva EG, Mel'nikova TI, Kozeletskaia KN, Kiselev AS, Rusinov VL, Charushin VN, Chupakhin ON.

Vopr Virusol. 2012 Nov-Dec;57(6):9-12. Russian.

PMID:
23477247
41.

[Immunosuppression at pregnancy and flu].

Kiselev OI.

Vopr Virusol. 2012 Nov-Dec;57(6):5-8. Review. Russian.

PMID:
23477246
42.

Immunogenicity and protective efficacy of candidate universal influenza A nanovaccines produced in plants by Tobacco mosaic virus-based vectors.

Petukhova NV, Gasanova TV, Stepanova LA, Rusova OA, Potapchuk MV, Korotkov AV, Skurat EV, Tsybalova LM, Kiselev OI, Ivanov PA, Atabekov JG.

Curr Pharm Des. 2013;19(31):5587-600.

PMID:
23394564
43.

The use of transient expression systems for the rapid production of virus-like particles in plants.

Thuenemann EC, Lenzi P, Love AJ, Taliansky M, Bécares M, Zuñiga S, Enjuanes L, Zahmanova GG, Minkov IN, Matić S, Noris E, Meyers A, Hattingh A, Rybicki EP, Kiselev OI, Ravin NV, Eldarov MA, Skryabin KG, Lomonossoff GP.

Curr Pharm Des. 2013;19(31):5564-73. Review.

PMID:
23394559
44.

Recombinant influenza vaccines.

Sedova ES, Shcherbinin DN, Migunov AI, Smirnov IuA, Logunov DIu, Shmarov MM, Tsybalova LM, Naroditskiĭ BS, Kiselev OI, Gintsburg AL.

Acta Naturae. 2012 Oct;4(4):17-27.

45.

Transmission studies resume for avian flu.

Fouchier RA, García-Sastre A, Kawaoka Y, Barclay WS, Bouvier NM, Brown IH, Capua I, Chen H, Compans RW, Couch RB, Cox NJ, Doherty PC, Donis RO, Feldmann H, Guan Y, Katz JM, Kiselev OI, Klenk HD, Kobinger G, Liu J, Liu X, Lowen A, Mettenleiter TC, Osterhaus AD, Palese P, Peiris JS, Perez DR, Richt JA, Schultz-Cherry S, Steel J, Subbarao K, Swayne DE, Takimoto T, Tashiro M, Taubenberger JK, Thomas PG, Tripp RA, Tumpey TM, Webby RJ, Webster RG.

Science. 2013 Feb 1;339(6119):520-1. doi: 10.1126/science.1235140. Epub 2013 Jan 23. No abstract available.

46.

INFLUENZA SURVEILLANCE IN RUSSIA BASED ON EPIDEMIOLOGICAL AND LABORATORY DATA FOR THE PERIOD FROM 2005 TO 2012.

Anna S, Burtseva E, Eropkin M, Karpova L, Zarubaev V, Smorodintseva E, Konovalova N, Danilenko D, Prokopetz A, Grudinin M, Pisareva M, Anfimov P, Stolyarov K, Kiselev O, Shevchenko E, Ivanova V, Trushakova S, Breslav N, Lvov D, Klimov A, Moen A, Cox N.

Am J Infect Dis. 2013;9(3):77-93.

47.

[Deitiforine, an antiinfluenza chemotherapeutic].

Tandura SN, Zarubaev VV, Anfimov PM, Kiselev OI.

Antibiot Khimioter. 2013;58(1-2):36-48. Review. Russian.

PMID:
24640143
48.

[Technological approaches to development of whole-virion inactivated vaccine from recombinant strain against A/H5N1 influenza in the Republic of Kazakhstan].

Kydyrbaev ZhK, Mamadaliev SM, Asanzhanova NN, Tabynov KK, Ryskel'dinova ShZh, Cherviakova OV, Sandybaev NT, Khaĭrullin BM, Kiselev OI.

Zh Mikrobiol Epidemiol Immunobiol. 2012 Sep-Oct;(5):54-9. Russian.

PMID:
23163037
49.

[Molecular-biological properties of the rubella virus strains isolated in St. Petersburg].

Buzitskaia ZhV, Sirotkin AK, Gudkova TM, Prochukhanova AP, Karpov AV, Tsybalova LM, Kiselev OI.

Mol Biol (Mosk). 2012 Jul-Aug;46(4):672-6. Russian.

PMID:
23113357
50.

Anti-viral activity of (-)- and (+)-usnic acids and their derivatives against influenza virus A(H1N1)2009.

Sokolov DN, Zarubaev VV, Shtro AA, Polovinka MP, Luzina OA, Komarova NI, Salakhutdinov NF, Kiselev OI.

Bioorg Med Chem Lett. 2012 Dec 1;22(23):7060-4. doi: 10.1016/j.bmcl.2012.09.084. Epub 2012 Oct 4.

PMID:
23099095

Supplemental Content

Loading ...
Support Center